These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31600525)

  • 61. Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.
    Lifschitz A; Virkel G; Mastromarino M; Lanusse C
    Vet Res Commun; 1997 Apr; 21(3):201-11. PubMed ID: 9090047
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of pharmacological interactions after administration of a levamisole, albendazole and ivermectin triple combination in lambs.
    Suarez G; Alvarez L; Castells D; Moreno L; Fagiolino P; Lanusse C
    Vet Parasitol; 2014 Mar; 201(1-2):110-9. PubMed ID: 24462508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement of Antialveolar Echinococcosis Efficacy of Albendazole by a Novel Nanocrystalline Formulation with Enhanced Oral Bioavailability.
    Hu C; Liu Z; Liu C; Zhang Y; Fan H; Qian F
    ACS Infect Dis; 2020 May; 6(5):802-810. PubMed ID: 31576751
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Genotype and Sex of the Host on the Bioavailability of Novel Albendazole Microcrystals Based on Chitosan and Cellulose Derivatives.
    Codina AV; Priotti J; Leonardi D; Vasconi MD; Hinrichsen LI; Lamas MC
    AAPS PharmSciTech; 2020 May; 21(5):149. PubMed ID: 32435903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology].
    Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P
    Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration.
    Cai ZY; Galettis P; Lu Y; Morris DL; Pourgholami MH
    Anticancer Res; 2007; 27(1A):417-22. PubMed ID: 17352262
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
    Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
    Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics.
    Lanusse CE; Gascon LH; Prichard RK
    J Vet Pharmacol Ther; 1993 Mar; 16(1):38-47. PubMed ID: 8478999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.
    Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A
    Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nutritional condition affects the disposition kinetics of albendazole in cattle.
    Sánchez SF; Alvarez LI; Lanusse CE
    Xenobiotica; 1996 Mar; 26(3):307-19. PubMed ID: 8730922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis.
    Permana AD; Paredes AJ; Zanutto FV; Amir MN; Ismail I; Bahar MA; Sumarheni ; Palma SD; Donnelly RF
    ACS Appl Mater Interfaces; 2021 Aug; 13(32):38745-38760. PubMed ID: 34353029
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
    Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
    Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Severe forms of neurocysticercosis: treatment with albendazole.
    Agapejev S; Da Silva MD; Ueda AK
    Arq Neuropsiquiatr; 1996 Mar; 54(1):82-93. PubMed ID: 8736150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Concomitant steroid and albendazole for treating neurocysticercosis.
    Shahid SK; Singhi PD
    Indian Pediatr; 1999 Nov; 36(11):1176. PubMed ID: 10745352
    [No Abstract]   [Full Text] [Related]  

  • 76. Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs.
    de Almeida Leandro L; Fraga CM; de Souza Lino R; Vinaud MC
    Parasitol Res; 2014 Apr; 113(4):1313-7. PubMed ID: 24481905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide.
    Pettarin M; Bolger MB; Chronowska M; Kostewicz ES
    Eur J Pharm Sci; 2020 Dec; 155():105552. PubMed ID: 32937212
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
    Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
    Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
    Kalra V; Dua T; Kumar V
    J Pediatr; 2003 Jul; 143(1):111-4. PubMed ID: 12915835
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of intestinal trichinellosis on oral bioavailability of albendazole in mice.
    Rodríguez JJ; de Prada I; Durán JJ; Fernández FB
    Parasitol Res; 2009 Jul; 105(1):65-70. PubMed ID: 19241092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.